Cardiometabolic Prevention Clinic for Cardiovascular Disease
(DUKE PREVENT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special clinic, staffed by heart, kidney, diabetes, and liver specialists, can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. Participants will either continue their usual care or receive coordinated care at the Duke Cardiometabolic Prevention Clinic, a specialized healthcare service. The researchers aim to assess whether this new approach improves health outcomes, such as reducing hospital visits and enhancing medication use, over 12 months. This trial suits adults with a history of heart problems and type 2 diabetes who have experienced high blood pressure and cholesterol in the past three months. As an unphased trial, it offers a unique opportunity to explore innovative care strategies that could enhance health management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this clinic protocol is safe for patients with type 2 diabetes and heart disease?
Research shows that referring patients to the Duke Cardiometabolic Prevention Clinic is generally safe. This clinic helps individuals with type 2 diabetes and heart disease manage their health more effectively. Specialists for the heart, kidneys, diabetes, and liver collaborate to enhance heart and metabolic health.
Previous studies have demonstrated that coordinated care effectively controls blood pressure and cholesterol levels. Reports of major safety issues with this approach are absent. Instead, it often results in better health outcomes by ensuring patients receive appropriate medications and lifestyle guidance. Overall, this approach is well-tolerated and can potentially reduce hospital visits.12345Why are researchers excited about this trial?
Researchers are excited about the Duke Cardiometabolic Prevention Clinic approach because it offers a personalized and coordinated care strategy for preventing cardiovascular disease. Unlike standard treatments, which typically involve routine check-ups with a primary care provider, this clinic involves a multidisciplinary team that evaluates and manages each patient's unique risk factors. This can include referrals to specialists in areas like endocrinology, nephrology, or hepatology, offering a more comprehensive management of heart and metabolic health. By focusing on a tailored prevention plan, the clinic aims to address the root causes of cardiometabolic issues more effectively.
What evidence suggests that the Duke Cardiometabolic Prevention Clinic is effective for managing type 2 diabetes and heart disease?
Research has shown that a team of doctors working together in a clinic can greatly improve health for people with type 2 diabetes and heart disease. In this trial, participants referred to the Duke Cardiometabolic Prevention Clinic will receive coordinated care from specialists, which may include heart and diabetes doctors. Studies have found that when such specialists collaborate, patients often have better control of their blood pressure and cholesterol. For example, one study found that patients who visited a heart specialist clinic had improved blood pressure and cholesterol levels over two years. These clinics help people manage their conditions through education, lifestyle changes, and medication management. Overall, this approach has been linked to more use of recommended heart medications and fewer hospital visits.12356
Who Is on the Research Team?
Neha J Pagidipati, MD, MPH
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for people with type 2 diabetes and heart disease who struggle to control their blood pressure and cholesterol. Participants should not be currently receiving multidisciplinary care for these conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Evaluation
Participants meet with a cardiologist for an initial evaluation and are referred to other specialists based on their needs
Treatment
Participants receive ongoing, coordinated care from a team of specialists to improve heart and metabolic health
Follow-up
Participants are monitored for changes in LDL-C, systolic blood pressure, and healthcare utilization
What Are the Treatments Tested in This Trial?
Interventions
- Referral to the Duke Cardiometabolic Prevention Clinic
Trial Overview
The study tests if a specialized clinic with a team of heart, kidney, diabetes, and liver specialists can better manage cardiovascular risks compared to usual care from primary providers over a year.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants referred to the Duke Cardiometabolic Prevention Clinic will be evaluated by a cardiology provider and receive coordinated care based on their risk factors. This may include referrals to specialists in endocrinology, nephrology, or hepatology. A multidisciplinary team will manage their care to help improve heart and metabolic health.
Participants in the standard care group will not be contacted directly and will continue their usual care with their primary care provider.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Barnhill Family Foundation
Collaborator
Citations
Duke Cardiometabolic Prevention Clinic's Impact on High- ...
The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic ...
Duke Cardiometabolic Prevention South Durham
We help people manage their disease risk factors through education, lifestyle changes, medication management, and referrals to other specialists as needed. Our ...
Association of Cardiologist Clinic Visits With ...
Primary outcomes were blood pressure control (<140/90 mm Hg) and lipid control (low-density lipoprotein cholesterol ≤100 mg/dL) over 2 years and ...
Cardiometabolic Prevention Clinic for Cardiovascular ...
The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, ...
Duke Cardiometabolic Prevention Clinic's Impact on High- ...
The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke ...
Association of Cardiologist Clinic Visits with Cardiovascular ...
Primary outcomes were blood pressure control (<140/90 mmHg) and lipid control (LDL-C ≤ 100 mg/dl) over 2 years and time to first major adverse ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.